HORTON D R INC /DE/ Amended Passive Investment Disclosure
The Vanguard Group filed Amendment No. 15 to a Schedule 13G/A reporting that it beneficially owns 0 shares (0%) of DR Horton Inc common stock as part of an internal realignment dated January 12, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 15 to a Schedule 13G/A reporting that it beneficially owns 0 shares (0%) of DR Horton Inc common stock as part of an internal realignment dated January 12, 2026. The amendment states certain Vanguard subsidiaries will report holdings separately following SEC Release No. 34-39538.
Insights
Amendment documents reporting structure change, not a market trade.
The filing records that The Vanguard Group now reports zero beneficial ownership of DR Horton Inc common stock, attributing holdings to disaggregated subsidiaries after an internal reorganization referenced to SEC Release No. 34-39538.
This is an administrative reporting change; cash‑flow treatment and any subsidiary holdings are not detailed in the excerpt. Subsequent filings by the reporting subsidiaries may show their respective positions.
AI-generated analysis. How Rhea-AI works. Not financial advice.